COVID: Updated Moderna bivalent booster authorized



Health Canada has authorized an up to date model of Moderna’s COVID-19 booster vaccine.

The new bivalent shot targets the Omicron BA.4/BA.5 subvariants and is supposed for use as a booster dose for these aged 18 years and older.

It comes two months after Health Canada authorized a bivalent booster from Moderna that focused the Omicron BA.1 subvariant and the unique pressure.

Health Canada says a bivalent booster triggers “a powerful immune response” towards each of the more moderen Omicron subvariants, in addition to the unique SARS-CoV-2 virus strains.

The National Advisory Committee on Immunization says Omicron BA.4 and BA.5 are the dominant strains in circulation.

They function a number of key mutations from the unique SARS-CoV-2 virus, main NACI to strongly suggest bivalent boosters that concentrate on Omicron.

On Oct. 7, Health Canada authorized the Pfizer-BioNTech’s bivalent booster for folks aged 12 and older. It additionally targets the Omicron BA.4 and BA.5 subvariants.

This report by The Canadian Press was first printed Nov. 3, 2022.


Please enter your comment!
Please enter your name here